Safety and Immunogenicity of SCB-2019 in Children <18 Years of Age (clinicaltrials.gov) - Aug 24, 2022 - P2/3 | N=3820 | Not yet recruiting | Sponsor: Clover Biopharmaceuticals AUS Pty Ltd | Initiation date: Jul 2022 ➔ Jan 2023
Trial initiation date • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
|